NEW YORK (GenomeWeb News) — Empire Genomics has licensed Roswell Park Cancer Institute’s genomic libraries, and will temporarily use its laboratory space, equipment, and expertise, RPCI said today.
Empire Genomics, a spin-out of RPCI and the University of Buffalo that offers human and mouse BAC microarrays, is developing a prenatal and postnatal diagnostic array using RPCI’s genomic libraries that will test for 100 different microdeletions, including those linked to various diseases.
Empire President and CEO Anthony Johnson said the company expects to continue to operate out of RPCI’s labs for around a year, and then to move into new facilities on the Buffalo Niagara Medical Campus, near the RPCI.
Johnson said the company expects to hire as many as 60 new staffers over the next five years.
Financial terms of the agreement were not released.